Meadow Creek Investment Management’s AstraZeneca AZN Stock Holding History

Meadow Creek Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$469K	Buy	5,258 +2,101	+67%	+$182K	0.01%	743
2019 Q2	$261K	Buy	3,157 +495	+19%	+$38.8K	0.01%	947
2019 Q1	$215K	Buy	2,662 +561	+27%	+$44.2K	﹤0.01%	990
2018 Q4	$160K	Sell	2,101 -4,158	-66%	-$325K	﹤0.01%	1033
2018 Q3	$495K	Hold	6,259	–	–	0.01%	728
2018 Q2	$440K	Buy	6,259 +352	+6%	+$25.3K	0.01%	695
2018 Q1	$413K	Hold	5,907	–	–	0.01%	719
2017 Q4	$410K	Hold	5,907	–	–	0.01%	731
2017 Q3	$400K	Hold	5,907	–	–	0.01%	675
2017 Q2	$403K	Hold	5,907	–	–	0.01%	653
2017 Q1	$368K	Hold	5,907	–	–	0.01%	620
2016 Q4	$323K	Buy	+5,907	New	+$335K	0.01%	612

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Meadow Creek Investment Management's AZN Position: Q3 2019 in Review

Meadow Creek Investment Management increased its AstraZeneca (AZN) stake by 67% in Q3 2019, buying an estimated $182K and bringing the position to 5,258 shares worth $469K. The position accounts for 0.01% of the portfolio, ranked #743.

Meadow Creek Investment Management first reported a position in AZN in Q4 2016 and has held it in 12 quarters since. The position peaked at $495K in Q3 2018. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

Meadow Creek Investment Management held 5,258 shares of AstraZeneca worth $469K as of Q3 2019.
Meadow Creek Investment Management bought 2,101 AstraZeneca shares in Q3 2019, an estimated $182K.
AstraZeneca made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #743 holding.
Meadow Creek Investment Management first reported a position in AstraZeneca in Q4 2016 and has held it in 12 quarters since.
Meadow Creek Investment Management's AstraZeneca position peaked at $495K in Q3 2018.
555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.